chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient felt anxious before receiving his vaccine, after administration he stated he doesn't feel good.  He layed on a bed for a while and drink water and was monitored for 30minutes. He refused for his blood pressure and pulse to be taken, Spo2 98%.   He stated he felt good afterwards, no acute ditress noted. He left the clinic in a stable condition, accompained by a family member
Information has been received from a health professional concerning a 6-year-old white male student who on 10/13/2000 at 10:00 AM was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) (Lot #635452/0768K). It was noted that the patient had a rash at the time of vaccination. On 10/03/2005 at 2:00 PM the patient developed chickenpox. Subsequently, the patient recovered. Additional information has been requested.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 3:21 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 3:21 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of the patient was reported as 30.27.  Concomitant medication of the patient was not reported.  Batch number 044B21A underwent temperature excursion on 15-Apr-2021 with temperature of 34 degrees Fahrenheit at 09:00 AM. These vials were moved to fridge on 06-Apr-2021 and beyond use date for the vials was reported as 09-May-2021. The vaccines moved to clinic on 15-Apr-2021. Storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination. Vials were only punctured right before administration. Vaccines were not frozen at time of administration and prior to administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. The reporter reported that, no data logger reports were available and traceable temperature monitor was used to record hourly temperatures.  No treatment information was provided by the reporter.
Information has been received from a nurse concerning four patients who on unspecified dates was vaccinated with a dose of VARIVAX (Merck) (LOT# not reported). On unreported dates, after vaccination, the patients experienced local injection site reactions. No further information was available at the time of this report. Follow-up information has been received from a nurse concerning a 10 year old female who in the week or so of 24-JUL-2009 was vaccinated with a dose of VARIVAX (Merck) (LOT# 66420/0797Y). "During the week or so of 24-JUL-2009", the patient experienced injection site reactions. She had recovered at the time of this report. Follow-up information has been received from a registered nurse concerning the 10 year old female who on 31-JUL-2009 was vaccinated subcutaneously with the second dose of VARIVAX (Merck) (LOT# 664620/0797Y). Concomitant vaccination included a dose of VAQTA (663683/1715X), IM, on the same day. On 01-AUG-2009, the patient experienced local injection site reaction to varicella described as with warm, itchy, red and swollen. The patient was treated with cool compresses and observation. The patient had recovered on an unspecified date. A lot check has been initiated. This is one of several reports from the same source. Additional information has been requested.
sick; Initial information was received on 18-Nov-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional (patient) via social media.  This case is linked to cases 2020SA357039 and 2020SA357040 (patient's mom and aunt).  This case involves patient (demographics unknown) who was sick (illness), when received INFLUENZA VACCINE.  Medical history, medical treatment(s), past vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick (illness) (unknown latency, non-serious event) following the administration of INFLUENZA VACCINE.  No laboratory data was reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Immediate Lumbar Muscle Spasms x 15 minutes.  Relieved with massage, and heat. Oxygen administered at 2L/min via nasal cannula to alleviate anxiety of situation.  NO SOB, NO Rash, NO medications given to reverse event.
10 days after administration began feeling increased lethargy, then developed chills with fever up to 100.2F and finally a mild rash on face and neck
Information has been received from a health professional concerning a 6 year old white male who on 04/04/97 was vaccinated SC with Varivax. On 02/04/02, the patient experienced breakthrough varicella on his face, neck and trunk. He recovered without any prescription medications within one week. The experience did not require any hospitalization.
Nine days after vaccination got large painful itchy lump on arm. Next day even bigger, harder and very red! Took Benadryl and redness and swelling going down 6 hours later.
Sore throat; This is a spontaneous report received from a contactable consumer(patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiry date were not reported) via an unspecified route of administration, at the age of 43-year-old, on 28Aug2021 15:30, at the left arm, at dose 1, single for covid-19 immunisation in a Pharmacy/drug store. Relevant medical history was reported as none. Concomitant medications were as none. The patient had no known allergies. The patient is not pregnant at the time of vaccination. The patient did not have other vaccine in four weeks. The patient did not have other medications in two weeks. The patient did not have prior COVID vaccination and was not tested post vaccination. On 28Aug2021 22:00, the patient experienced sore throat. The patient did not receive treatment in response to the events. The outcome of the event was unknown at the time of report.  The lot number for BNT162B2, was not provided and will be requested during follow up.
arm was sore; woke up drenched in sweat; felt drained / lack of energy; clammy; muscle pains; having very vivid, unusual dreams including snakes and dinosaurs chasing him; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 01Mar2021 (Batch/Lot number: unknown) as dose 1 single for covid-19 immunisation. Relevant medical history included: "back pain" (unspecified if ongoing), notes: smoke medical marijuana for back pain, few glasses of wine a few days a week. The patient took concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm was sore"; HYPERHIDROSIS (non-serious), outcome "unknown", described as "woke up drenched in sweat"; ASTHENIA (non-serious), outcome "unknown", described as "felt drained / lack of energy"; COLD SWEAT (non-serious), outcome "unknown", described as "clammy"; MYALGIA (non-serious), outcome "unknown", described as "muscle pains"; ABNORMAL DREAMS (non-serious), outcome "unknown", described as "having very vivid, unusual dreams including snakes and dinosaurs chasing him"; FATIGUE (non-serious), outcome "unknown", described as "fatigue". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
itchy arm near the vaccine shot, redness, swelling and warm to touch.  still experiencing the same three days in a row.
Very dizzy, vomiting, vision change, stiff neck, headache, brain fog, could't think or talk right, hands shaking, fever, tingling in head  couldn't get out of bed or stand no more than 20 mins this lasted very strong for 5 months.
On my second does the same night on 1/13/2021 I started feeling nauseas. The next morning on 1/14/2021 I felt horrible, my stomach was hurting, my left arm was swollen, felt really weak & tired, I had a lot of fatigue & I felt very nauseas. It last 24 hrs.
Had vaccination at 2 pm - went home and went to sleep - woke up about 6 pm - severe trouble breathing and heart racing - called Help Line - they said heart rate was elevated - call 911 - transported by ambulance to Hospital - used oxygen and IV fluid in ambulance - did EKG/ECG at hospital - Doctor said patient had "sinus arythmia"? Follow up with Dr. next week.
She received some immunizations day before being seen. 3-4 Hrs later she developed high fever to 103. She has no other symptoms now, except for a little runny nose, which she has had for about 1 wk. After her first set of shots, she had a high fever to 104 lasting 72 hrs, along with her twin sister. With the second set of shots, she had no reactions. The fever after the first set of shots started 3-4 hours after receiving the immunizations and lasted 72 hrs. The shots that were given both first and third times are the HIB and PREVNAR.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 1:16 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 56.78.  Concomitant products were not provided.  On 03-Apr-2021, Excursion time was 09 AM, temperature was 34, total doses given for the day was 210, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 30-Mar-2021, vial was moved to clinic on 03-Apr-2021. 20 vials were sent to clinic. Vaccine BUD date was 29-Apr-2021.  On 03-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: 38, 9AM: 34,10 AM: 38, 11AM: 42, 12 PM, 1 PM and 2 PM: 41, 3 PM and 4 PM: 40.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Information has been received from a nurse concerning a 60-year-old female who on 04-DEC-2007 was vaccinated with one dose of Zostavax (Oka/Merck). On 16-FEB-2008 "last Saturday" the patient returned to the clinic with a rash on her palms and upper left arm. The nurse said it was shingles. At the time of the report the patient's status was unknown. A product quality complaint was not involved. Additional information has been requested.
I woke up at 6 am with right calf pain and burninig in right calf. The pain continues to be intermittent. After a few days, the same pain/burning went up to right thigh. Every few days the same symptoms continued to go up the right side of my body (buttocks, back) and then it started in my right arm. I started having a pain where the shot was given to me and numbness, tingling and burning down to my fingers.  All symptoms are unilateral and at this time continues intermittently throughout the day and has progressed up to right shoulder. I have not seeked treatment at this time, but continue to monitor symptoms.
Fatigue; Headache; Skin plaque; This spontaneous case was reported by a consumer and describes the occurrence of SKIN PLAQUE (Skin plaque), FATIGUE (Fatigue) and HEADACHE (Headache) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriasis.    Concurrent medical conditions included Psoriasis.   On 19-Mar-2021, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced SKIN PLAQUE (Skin plaque). On an unknown date, the patient experienced FATIGUE (Fatigue) and HEADACHE (Headache). In 2021, SKIN PLAQUE (Skin plaque) had resolved. At the time of the report, FATIGUE (Fatigue) and HEADACHE (Headache) had resolved.            There was no reported medical history.  Concomitant medications details were not reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.   The reporter's causality for the event of Fatigue, Headache was reported as no reasonable possibility and for Skin plaque was reported as reasonable possibility for Humira.  No treatment medication were provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
1/2 hour post vax, the pt complained of itching, tearing, swelling of lips and face and induration at injection site. Benadryl given 2 times and the pt was observed in office. Symptoms subsided and the pt was discharged home.
The vaccine vial was not diluted before injection. The patient was given 0.2 mL dose from an undiluted vial.
01/20/22 presents to  ED for "was eating and aspirated". PMHX of "Liver failure, Anxiety, Asthma, BCC, DM, Bipolar, GERD, and Pulm HTN"
pt recvd vax;began fever 103-104 15dec; 16dec rash, loss of apetite;17dec dec urination & dec eat & drink; visit to er; given motrin & apap;18dec fever 106 for 1hr 45 mins; 19dec fever 99;
7 year old male received an influenza vaccine in the right upper extremity today. Within 30 minutes of the injection his mother noticed that he complained of right arm pain and began crying. He became somewhat upset and anxious. His mother thought she noted a rash around his eyes. She did not notice a rash on the trunk. The child complained of difficulty breathing briefly. The mother noted no cyanosis or altered state of consciousness. No nausea, vomiting, or fever. She called the office and was advised to give a dose of Benadryl and return for reevaluation immediately. She presented within 30 to 45 minutes of this phone call.
A non-serious spontaneous report of FLUMIST INADVERTENTLY ADMINISTERED TO AN ASTHMATIC was received from a nurse concerning a five-year-old male. The patient's medical history included asthma. Drug history information included previous injectable dose of a flu vaccine in the previous month. The patient received FLUMIST on 08Nov2007. On 03Oct2007, the child received an injectable dose of flu vaccine. On 08Nov2007, the child was inadvertently administered FLUMIST by his school. There were no adverse events reported. The reporter did not provide a causality assessment. The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable.
10:11 about 25 minutes after 2nd Moderna shot patient stated mouth, tongue, lips feel itchy, breathing is fine, no swelling, no other symptoms , gave 50mg dose of Benadryl at 10:13am , pt stated feeling better after about 15 minutes, continued to watch/monitor for an hour , pt stated feelilng fine and appeared to be fine, boyfriend was with her , so  she did not leave alone.
Fatigue for 1 week 2 days post vaccine. Mild to moderate. Significant dizziness.
after her first shot on FEB 24 she began looking white as ghost. She was very weak, unstable, in pain, and felt like her life force was getting drained out of her. Then her 2nd shot on MAR 24 and she continued to not feel good. On May 9th she lost consciousness on the bathroom floor, rushed to the ER. She was admitted and told she had pneumonia. By that evening she could not breathe. Her lungs filled with blood and she was dead within 6 days.
Muscle aches next day after injection 2; Tinnitus lasting 4 hours began 1 hour after injection; Washed out feeling; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in the left arm on 26Mar2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included elevated blood pressure. The patient had known allergies to medications, food, or other products. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the left arm on 05Mar2021 at 11:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 13:30, the patient experienced tinnitus lasted 4 hours began 1 hour after the vaccination and muscle aches next day after injection 2. The patient had washed out feeling lasted day one and day two after the second injection. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events tinnitus was resolved on 26Mar2021, washed out was resolved on 27Mar2021 and muscle ache was resolved on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
The pt experienced a 1/4" diameter subcutaneous cyst at location of vax. Cyst present since immunization.
According to his daughter, patient did not appear to have any ill effects from his second COVID-19 vaccine on 03/09/2021. However, on 03/11/2021, he suffered what is suspected to be a fatal arrhythmia/myocardial infarction. It is unknown if there is any correlation to the vaccine.
Patient experienced symptoms consistent with vaso-vagal syncope approximately 5 minutes after injection: palor, diaphoresis, dizziness. Patient recovered within 30 minutes with rest and water.
Headache, heavy around the chest area, cough, fatigue, muscle pain, and joint pain with nausea.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients. The patients' medical history was not reported. In approximately 2015 (reported as since 11-AUG-2015), the patients were vaccinated with doses of oral, ROTATEQ lot # K020181, expiration date reported as 24-JUN-2016 (dose, route and site of administration were not reported) which were exposed to the temperatures outside of the recommended range. No adverse effect was reported. Additional information has been requested.
My arm now has red rash on the upper portion of right arm where shot was done.    I am concerned now about getting second vaccination; especially since this was such a long delay.  My arm did start mildly hurting after about nine hours and then eased about 24 hours after that.
Measles-like rash on bottom of forearms, and to a lesser extent on legs.
Information has been received from a registered nurse concerning a female "between 70 to 80 years of age", who in August 2007, was vaccinated intramuscularly with a 0.5mL dose of PNEUMOVAX 23.  Concomitant therapy included tetanus toxoid.  Subsequently, the patient developed redness at the injection site.  The patient sought unspecified medical attention.  The patient was placed on prednisone.  No laboratory diagnostics were performed.  The patient recovered on an unspecified date.  No product quality complaint was involved.  This report is one of three from the same source.  Additional information has been requested.
This spontaneous report as received from an unspecified other (Control #54417) concerning a 77 year old female patient. Medical history and concurrent conditions were not reported. Patient had no known allergies. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 (dose and route were not reported) Lot # J011651; Expiration date: 22-AUG-2015 (reported as 31-AUG-2014). In 2014, the patient had swelling of the arm, body aches, weak and fever. Patient did not had any trouble breathing and have no known allergies. Once patient was put on antibiotics, patient got better. The outcome of the events was not reported. This is one of 4 reports from the same reporter. Additional information has been requested.
Syncope, dizziness, BPs 99/62 (pulse 62), 108/67 (pulse 64), O2 sats 97%.